Monday, September 14, 2026

Sanctions Who? North Korean Art Sold in Russia Despite UN Bans

Radio Free Asia (RFA) reported that a...

2026 Chevrolet Trailblazer Debuts With New Colors and a Bold ACTIV Trim

GM Korea launches the 2026 Chevrolet Trailblazer with new trims and colors, maintaining competitive pricing for its popular SUV.

BROTHERS NO MORE, ENEMIES ‘Til Death : Kim’s Sinister “Two-State” Doctrine Ignites The Fuse For A Bloody Second Korean War!

North Korea will hold elections for the Supreme People's Assembly on March 15, 2026, prioritizing legislative changes post-party congress.

Tag: Zymfentra

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Celltrion’s Zymfentra Just Hit a New U.S. Prescription Record and the Growth Looks Serious

Celltrion's Zymfentra treatment saw a 185% surge in U.S. prescriptions, driven by effective marketing and reimbursement strategies.

How Celltrion’s Local Production Strategy Eliminates U.S. Drug Tariffs Influence

Celltrion resolves tariff impacts on U.S. sales, boosting local production and growth opportunities for its biosimilars, including Zymfentra.

How Zymfentra’s Prescription Rates Tripled in January: A Game-Changer for Celltrion

Celltrion's Zymfentra sees a 213% rise in U.S. prescriptions, marking significant growth since its launch, driven by market demand.

Celltrion’s Zymfentra: How This Breakthrough Drug is Driving Record Sales

Celltrion expects record sales driven by Zymfentra's success, expanding into new biosimilars and CDMO business for future growth.

K-Bio Targets the U.S. Market: Celltrion and Samsung Bioepis Close in on Originator Drugs

Celltrion and Samsung Bioepis are expanding in the U.S. market, showing strong growth in biosimilars like Zymfentra and Hadlima.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.